Mariner, LLC Vera Therapeutics, Inc. Transaction History
Mariner, LLC
- $58.4 Billion
- Q4 2024
A detailed history of Mariner, LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Mariner, LLC holds 5,966 shares of VERA stock, worth $168,121. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,966
Previous 5,795
2.95%
Holding current value
$168,121
Previous $256,000
1.56%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$158 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$123 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$94.1 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$83.4 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$83.1 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $762M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...